LS Associates, a global consulting service designed to provide companies with “on demand” C-Suite leadership to flexibly and economically meet the strategic business needs of companies when they need experience the most. LS Associates leverages the expertise and network of the larger LifeSci Partners platform to deliver targeted and talented executives with relevant industry and subject matter expertise to companies at any stage of growth and transition. The LS Associates “Executive-as-a-Service” model will enable customizable access to talent in a cost-effective manner to provide trusted guidance through strategic milestones and evolving corporate needs.LifeSci Partners is the leading provider of global consulting services in the areas of investor relations, public relations, executive search and capital markets advisory. LifeSci combines deep domain expertise in the life sciences with decades of experience in capital markets and corporate communications to deliver unparalleled services to our clients in the life sciences.For further information please visit: http://www.lifescipartners.com/

On-demand consultancy providing C-Level guidance for MedTech/Med Device companies through all stages of growth and change.

Conductive Technologies Inc., (CTI) is a leading global OEM developer and manufacturer of electrochemical sensors, bio sensors, microfluidic devices and conductive membrane controls and switches.As President and Board Director:•Reversed declining revenue and profitability through a companywide restructuring, refinement of the product development pipeline, cost improvements, inventory reduction and improved on-time delivery.•Refocused the company's R&D towards the development of a platform of POC based testing products with the goal of establishing the CTI brand as a stand-alone.•Secured a multi-year DOD development and commercialization program for a market disrupting diagnostic tool that is now in final development.•Utilized contract manufacturing capabilities to capture COVID-19 test related revenue opportunities as key core customers were recovering from their respective market changes.•Posted 12% revenue increase for the fiscal year following the pandemic and fiscal YTD revenue vs. PYTD increased 72%.

Responsibility for Global Sales, Distribution and Customer Service for non-invasive Vital Signs monitoring equipment, sensors and related disposables.•Re-structured US direct and indirect sales channels including a re-alignment of sales management responsibilities and expansion of Independent Rep organization.•Aligned global sales and marketing into a cohesive and collaborative team.•2016 mid-year results: Achievement of Global Revenue Plan and KPIs for all markets served.•Implemented a repositioning of Nonin’s market image and products through the introduction of the COPD re-admission cost reduction initiative.•Member of Senior Operations Team.

Responsibility for Sales, Marketing and Customer Service for specialized NG and GI feeding tubes, PICC and the CORTRAK enteral feeding tube placement technologies. •Re-structured and expanded domestic sales organization and implemented new hiring profile.•Established and expanded clinical consulting group to support CORTRAK.•Established Centers of Reference for CORTRAK referrals and expanded clinical study portfolio.•Expanded website to include clinical training and education for CORTRAK.•Successfully launched second generation CORTRAK technology and implemented new pricing strategy and drove consistent double digit growth in units and revenue.•Successfully negotiated agreements with the top GPOs.•Member of the Executive Staff reporting to the company CEO.

VICE PRESIDENT SALES, NORTH AMERICA Responsibility for all Teleflex Medical product sales in the US: $610 million revenue, $60 million OPEX and 340 employees.•Managed the Critical Care, Surgical, Respiratory and Alternate Site sales forces, Customer Service, Corporate Sales and Clinical Support.•Successfully integrated the former Teleflex Medical, Surgical and Arrow sales organizations and Customer Service Departments achieving all synergy targets.•Developed the Strategic Plan for the anesthesia business segment which resulted in Board approval for the plan and expansion of a specialized anesthesia sales team.TELEFLEX acquired Arrow International, Inc. (October 2007)VICE PRESIDENT GENERAL MANAGER, ASIA PACIFIC (Arrow Int'l.)P&L responsibility for the $100 million revenue Asia / Pacific Business Unit including the Arrow Japan subsidiary, India representative office and the Australasia distributor network.•Established new distributor pricing structure for Australasia.•Realigned sales territories in Japan, hired a National Sales Director based in Tokyo.VICE PRESIDENT, VENOUS ACCESS BUSINESS UNIT (Arrow Int'l.)Global P&L responsibility for the $290+ million Venous Access Business Unit and the $30+ million Arrow Select Kit Customs group comprised of marketing, engineering, regulatory, quality assurance and manufacturing organized in a matrix structure.•Successfully launched two new products which accounted for 63% of the revenue growth for Arrow in 2007.•Implemented a re-branding initiative at the corporate level and across the entire critical care business resulting in extensive collateral material development, website re-skinning, and the establishment of a clinical resource website dedicated to Catheter Related Blood Stream Infections and risk reduction. (www.firstdonoharm.com)•Secured two exclusive distribution agreements providing Arrow with component product differentiation for procedural kits and entry into the hand-held ultrasound market.

VICE PRESIDENT MARKETING, SMITHS MEDICAL ASDGlobal Marketing responsibility for $240 million of Safety Devices, Arterial Blood Sampling, Airway and Pain Management product sales within the newly formed Anesthesia and Safety Device business unit.•Secured Board of Director approval for the largest capital investment by Smiths Medical at that time providing for additional manufacturing capacity to support the Safety Device business.•Secured $4 million OEM supply agreement with a top tier pharmaceutical company for Safety Devices. •Responsibility for the multi-disciplinary Marketing Department: product management, new business development, marketing services, marketing communication and budgets.VICE PRESIDENT SALES AND MARKETING, SPECIALTY PRODUCTSDirected US and UK based Sales Forces of 100+•Sales of Sharps Safety and Pain Management grew from $49.8 million to $107.5 million.•Developed Strategic Growth plan for Sharps Safety; results: Sales growth from $17 million to $44.7 million.•Restructured Specialty Products Sales Force into Sharps Safety / Pain Management Sales Forces.•Implemented a Challenger Branding platform•Integrated the Abbott anesthesia kit and tray acquisition valued at $25 million.•Integrated the MPS Acacia and Futura safety product lines.VICE PRESIDENT SALES AND MARKETING, PORTEXResponsibility for multi-disciplinary Sales and Marketing Departments: product management, new business development, marketing services, marketing communication,US based 100+ Sales organization comprised of field based reps, corporate contracts, customer service, custom products and sales training.•Sales of anesthesia, respiratory and safety products grew from $122.8 million to $166.1 million.•Secured an OEM agreement with Bayer Diagnostics for international sales of arterial blood sampling products valued at $3.5 million. Secured OEM agreement with Baxter for anesthesia masks valued at $400,000..

VICE PRESIDENT MARKETING, VASCULAR SYSTEMS (vascular implants, CP and IR products)DIRECTOR OF SALES, CARDIOSURGERY DIVISION (vascular implants, CP products)NATIONAL SALES MANAGER, CARDIOSURGERY DIVISION (vascular implants, CP products)DIVISION SALES MANAGER, IMPLANTS DIVISION (vascular implants)